Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial

Key Findings

• ●Long-term midostaurin efficacy confirmed with 10-year median follow-up

Referenced in (1 disease)

No validation events recorded yet. Source will be checked on the next kipine-source-validator run.